Pursuant to the provisions of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zenotech Laboratories has informed that the Board of Directors of the Company, at its meeting held on August 10, 2017, has considered and approved the Unaudited Financial Results along with Limited Review Report issued by the Statutory Auditors for the quarter ended June 30, 2017.
The above information is a part of company’s filings submitted to BSE.